We are an AI solution provider focusing on the sales of conversational AI products and solutions for daily life and healthcare related application scenarios in China. According to Frost & Sullivan, we remained the fourth largest AI solution provider by revenue. In 2024, we ranked third by revenue in AI Solution in Daily Life and fourth in AI Solution in Healthcare in China.
Since our inception, we have explored the AI technological innovation and led the progress of commercial application of AI technologies in China.
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2026
31
2026-07
Announcements and Notices
VOLUNTARY ANNOUNCEMENT LATEST BUSINESS DEVELOPMENTS
28
2026-07
Announcements and Notices
VOLUNTARY ANNOUNCEMENT COMPREHENSIVE UPGRADE OF SPEECH LARGE LANGUAGE MODELS U2-ASR AND U2-TTS
23
2026-07
Announcements and Notices
VOLUNTARY ANNOUNCEMENT IN RELATION TO THE INCREASE IN H SHAREHOLDING BY THE CONTROLLING SHAREHOLDER, EXECUTIVE DIRECTOR AND CHIEF EXECUTIVE OFFICER AND EXECUTIVE DIRECTOR
23
2026-07
Announcements and Notices
VOLUNTARY ANNOUNCEMENT INTENTION TO REPURCHASE SHARES ON THE MARKET
